Pharmacist-driven assessment and prescribing of COVID-19 therapeutics: A large, tertiary academic medical center’s experience

Abstract

Disclaimer In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.

The New Brunswick Pharmacy Assessment Clinic: A Novel, Pharmacist-Led, Virtual Collaborative Practice Hub for the Assessment and Prescribing of Nirmatrelvir/Ritonavir for Patients with COVID-19

“…The PAC pharmacists triaged referrals by urgency, according to the time since symptom onset, with patients on day 5 of symptoms being prioritized in light of evidence-based initiation time sensitivity. 23 Upon receipt of referrals, the PAC pharmacists completed virtual assessments through direct consultation of electronic health records. Assessment components included, but were not limited to, pharmacokinetic and pharmacodynamic drug interactions, date of symptom onset, laboratory values (notably renal and hepatic function), and patient preference.…”